Fred Gransville

I. A Pill Nation: The New Face of an Old Experiment

Imagine a mother at the pharmacy counter with prescription in hand, wavering under the pharmacist's gaze. Her seven-year-old has been diagnosed with Attention Deficit Hyperactivity Disorder, and the physician insists that Adderall is required to facilitate normal functioning in school. Across town, a thirty-something professional is microdosing LSD in order to get through a twelve-hour workday, praying for increased focus and creativity. Retirees are prescribed daily selective serotonin reuptake inhibitors (SSRIs), their emotions dulled, their compliance assured. There is no one coercing these patients. There are no white coats pinning them down. But they are, all the same, subjects of what constitutes a grand experiment-voluntary, corporate, and all but invisible.

Experiments like MKUltra once employed far more primitive methodology. LSD was given surreptitiously, electroshock resulted in psychological damage, and patients' autonomy was taken away in the name of medical therapy. Dr. Ewen Cameron's psychic driving tests at McGill University were the worst of the worst: human beings turned into cognitive tabula rasa, reconstructed to do the experimenter's bidding. People believed those horrors would never be repeated. But MKUltra did not disappear. It evolved. Its processes were legalized, industrialized, and normalized through the medium of pharmaceuticals.

Modern society trades the surreptitious syringe for the prescription pad. Sickness spreads through later editions of the Diagnostic and Statistical Manual of Mental Disorders. Hyperactive kids turn into patients. Depressed grown-ups turn into subjects. Fear gets pathologized to a chemistry issue to be solved. Each new diagnosis spawns a market for medication and yields a covert, insidious framework of control. Whereas MKUltra relied on force, Big Pharma relies on assent, acquiescence, and appearance of beneficence.

The experiment is not clandestine. It's corporate, legal, and everywhere. Every pill sold, every microdose ingested, every antidepressant swallowed is part of an enormous, rolling manipulation of consciousness. Society is doing it willingly, but not always aware of precedent in history or moral context. This is the dawn of a chemical society new, where the experiment continues, and the test subjects are the population at large. Better living through chemistry is antithetical to Blue Zone’s lifestyle – just the ingestion of one’s annual microplastics surely is too much, already.

II. From Dachau to Langley: The Origins of Pharmaceutical Mind Control

The history of modern drug control is ominous and historically specific. The Nazis established the moral standard for evil medical experimentation, and IG Farben-the chemical and pharmaceutical behemoth that encompassed Bayer, BASF, and Hoechst-performed gruesome human experiments on concentration camp prisoners. They were not abstractions of evil; they were systematic investigations of chemical, biological, and psychological manipulation. These prisoners endured hypothermia, forced sterilization, lethal toxins, and experimental medications, most of which resulted in death or permanent disability.

After World War II, the United States initiated Operation Paperclip, actively recruiting Nazi scientists and doctors. While a great deal of focus has been put on rocket scientists like Wernher von Braun, the operation also imported the skilled in mind control, chemical warfare, and human experimentation. Dr. Hubertus Strughold, "the father of space medicine," conducted hypothermia experiments on prisoners at Dachau before being brought to the United States to work for the Air Force. These scientists brought with them coercive knowledge of human experimentation that would have future use in secret programs like MKUltra. The Cold War atmosphere of the 1950s and 1960s fostered a climate of paranoia. The CIA, in fear of Soviet and Chinese breakthroughs in brainwashing, had an interest in controlling human behavior and thought. They employed psychoactive drugs such as LSD, mescaline, and other experimental substances in secret labs, psychiatric hospitals, and prisons. Unwitting test subjects included mental patients, prostitutes, and even the CIA agents themselves. Dr. Donald Ewen Cameron's "psychic driving" experiments at McGill University were the pinnacle of this practice: patients were administered repeated messages under the cover of high-dose electroconvulsive therapy and hallucinogens, erasing their psyches and attempting to reprogram them.

Universities, hospitals, and prisons served as handy laboratories for the agency, with pharmaceutical companies quasi-sanctioning the practice in their eagerness to test chemicals that could subsequently be crafted into lucrative medicines. Boundaries between secret experimentation and corporate research and development began to break down. Once prohibited, risky approaches were now legitimized in mainstream medical and business arenas. What had been learned in the European camps and secret laboratories of the CIA were models for contemporary pharmaceutical manipulation: subtle, systemic, and socially approved.

The legacy of Langley and Dachau is not confined to textbooks. It continues in the normalization of mass drugging, psychotropic medication as a tool of behavioral control, and the industrialized pathologization of human emotion. The question is no longer whether such programs are feasible, but how they continue to function today, cloaked in legality, marketed as healthcare, and accepted as normal by the public.

III. MKUltra's Shadow: How Covert Science Became Corporate Doctrine

MKUltra did not end with the scandal of its documents; it only transformed. The CIA's secret programs established a model for the pharmaceutical industry to advance experimentation in the cover of legitimacy. What had previously needed to be done secretly, coercively, and deceptively could now be done openly-through clinical trials, regulatory sanctions, and the tradition of consent. The syringe took the place of the prescription pad, the lab the pharmacy, and the subject and individual patient unwittingly.

The pharmaceutical industry honed the legal armor. Ethics review boards, informed consent protocols, and clinical trials provided the appearance of control while simultaneously legitimizing human experimentation on a previously unimaginable scale. Prison inmates served as test subjects for multi-billion-dollar tests, frequently unaware and bearing the complete burden of risk. In the South, diluted regulations allowed companies to test on susceptible populations in India, Africa, and Eastern Europe-de-facto experimentation outsourced to those least in a position to resist. Even the military is part of this continuum: amphetamine "go-pills" and experimental psychoactive medications are given to troops in the interest of performance and readiness.

Meanwhile, psychiatry itself was a tool of mass experiment. The expansion of the Diagnostic and Statistical Manual of Mental Disorders (DSM) normal pathologized human feelings, made bereavement, anxiety, and hyperactivity into chemical imbalances to be medicated. Each new diagnosis opened up a drug market, a subtle form of population control through personality and mood adjustments. Human difference, an opportunity to profit.

The coercive psychological methods once hidden behind CIA black sites are now accomplished through ad campaigns, marketing budgets, and corporate lobbying. Mega corporations such as Johnson & Johnson, Eli Lilly, and Pfizer ensure that doctors, as well as patients, perceive their drugs as necessary, beneficial, and safe. As these corporations track outcomes, side effects, and dependency patterns, they are effectively conducting ongoing experiments on the world's population.

MKUltra relied upon force and dissimulation. Big Pharma relies upon compliance and consent, the willing collaboration of patients who believe in the medical-industrial complex. And yet the results are eerily similar: human behavior is managed, emotions are manipulated, and addiction is fostered. Cold War secret science is corporate orthodoxy in the twenty-first century, legality and mass marketing replacing locks, chains, and black site labs.

The ghost of MKUltra haunts every pharmacy, prescription, and pill. The experiment expanded from hundreds of test subjects to millions of willing test subjects. The consequences-unbalanced neurochemistry, addiction, and subtle social control-are nothing less than profound, widespread, and all but unseen.

IV. A Tale of Two Societies: America and the Nordic Pharmaceutical Model

The experiment is not only in labs; it permeates the very social fabric of society itself. This is nowhere more evident than between the United States and the Nordic countries. They are both experimenting with chemical control of human behavior, but in different ways, offering different facets of the same system-wide experiment.

In the US, rising ADHD diagnoses and prescription of stimulant drugs such as Adderall and Ritalin have created a chemically treated group of children and adults. Marketing campaigns by drug companies such as Shire Pharmaceuticals have created awareness and brought inattentiveness and hyperactivity as drug-treatable conditions. The result is a culture of neurochemical enhancement as norm, of productivity by way of dependency, and of dependency as the result of systematized prescription patterns. It is an American model that expresses a cultural yearning for efficiency, concentration, and performance at the cost of voluntary intellectual freedom.

Contrast this with Sweden, Norway, and Denmark, where ADHD stimulant use is far more restrained, diagnostic criteria are rigorous, and the culture resists over-prescription. But those countries have consumed SSRIs and other antidepressants at record levels, pharmacologically treating anxiety, depression, and angst of living. In the Nordic utopia, populations are socially sedated by mood regulation, preferring conformity and contentment to hyper-productivity. Both approaches, despite their superficial difference, demonstrate an eagerness to experiment populations on with neurochemistry, trading natural emotional resistance for chemically induced compliance.

This binary demonstrates that pharmaceutical regulation is not solely an American phenomenon, but a worldwide practice adapted to local ideology and culture. America prizes stimulation and performance, while the Nordics prize calm and emotional control. But in either case, the outcome is the same: human behavior is controlled, autonomy is negotiated chemically, and addiction to corporate pharmacology is the norm.

Both models allude to a more profound reality: the subjugated citizenry has turned into the primary laboratory. Humans, relying on medical professionals and the pharmaceutical-industrial complex, unwittingly participate in an enormous social experiment. Neurochemistry is tested, behavior conditioned, and subtle control imposed, everything in the name of healthcare and the greater good. The specter of MKUltra, once clandestine and coercive, now operates openly, legally, and with general acquiescence.

V. Beyond Pills: Addiction, Opioids, and the Pharmaceutical Social Experiment

Not only does the pharmaceutical-industrial complex prescribe scrips, but it also carries out mass social experimentation. A real-life example is the opioid epidemic. Purdue Pharma's campaign to market OxyContin with a full seal of approval of the risk of addiction turned millions of unwitting subjects into a corporate experiment. Addiction, withdrawal, and overdose were secondary datapoints in an experiment more designed for corporate greed than human thriving.

Similarly, offshoring clinical trials to vulnerable groups in the Global South recalls the CIA's past experiments with prisoners and psychiatric patients under MKUltra. Individuals in India, Africa, and Eastern Europe have become subjects in trials for new psychoactive drugs, stimulants, and mood stabilizers. The trials are typically conducted under partial or misleading informed consent, reflecting a continuity of exploitation from Cold War secrecy to corporate legality in the twenty-first century.

Even the military is a laboratory, with stimulants, experimental psychoactives, and mood-alterers being administered to soldiers under the pressures of operations. The parallels with Edgewood Arsenal and the other covert programs are obvious: the state is still experimenting with neurochemistry, but now it is doing so through legally sanctioned, scientifically verified manipulations.

The evolution of psychiatry also makes this experiment possible on an ongoing basis. Broadened diagnosis medicalizes normal human experience, converting mourning, upset, and anxious experience into something chemically vulnerable. Medication are tools of behavioral control, influencing mood and thought on a population scale.

The complicit consent of the public, happily unaware of the structural incentives and historical origins of pharmaceutical marketing, disguises continuity of experimentation. MKUltra relied on secrecy and coercion; Big Pharma today relies on legality, consent, and cultural normalization. Although the needle has been replaced by the prescription pad, the mechanism-manipulating human behavior for corporate and institutional ends-remains.

The return on the investment is evident: mass dependency, insidious psychological and behavioral modification, and a society that has grown accustomed to chemical manipulation as a matter of course medicine. The experiment is ongoing-not in secret labs, but in classrooms, workplaces, and living rooms nationwide.

VI. The Historical Continuum: Nazis, Paperclip, and CIA Origins

The roots of pharmaceutical experimentation today are not recent and are no coincidence. They go directly back to World War II, to the Third Reich, and to the notion of clandestine intelligence activities. The twentieth-century chemical-industrial-military complex spawned the paradigm of treating human beings like guinea pigs.

The Nazi regime, funded by chemical cartels such as IG Farben (which included Bayer, BASF, and Hoechst), conducted horrific experiments on concentration camp victims. Hypothermia experiments, chemical toxicity, and psychoactive drug experiments were routine. The objective was not medicine, but control and domination-human beings reduced to statistics, pain measured scientifically.

After the war, the U.S. hired most of these scientists through Operation Paperclip, importing rocketry, chemical warfare, and human experimentation technology into the nation. Scientists such as Dr. Hubertus Strughold, later called the "father of space medicine," introduced hypothermia and torture experimentational expertise directly into the U.S. military-industrial complex. They were reassigned, not censured, instilling the ethics of experimental control into U.S. science and intelligence apparatus.

The CIA, fearing Soviet and Chinese experiments in mind control, started MKUltra in the 1950s and 1960s. There were unwitting victims numbering in the thousands-civilians, prisoners, and mental patients-who were given LSD, mescaline, and other psychoactive substances. The methods ranged from psychic driving to sensory deprivation in the hope of opening up the human mind and reprogramming it at will. Laboratories, hospitals, and universities were satellites in a massive covert investigation where legality was immaterial, and ethics were ignored.

Modern Big Pharma, by design or by the design of the system, carries on this historic trajectory. Legalized prescription amphetamines, SSRIs, mood stabilizers, and opioids are all voluntary uses of mind control, spread to mass populations. Where MKUltra had required secrecy and coercion, the new system depends on advertising, regulatory complicity, and civic trust. Citizens, voluntarily or through social conditioning, are still the subjects of experiments that seek to manipulate cognition, emotion, and behavior.

The family tree is straight: from Nazi pharmacological experimentation to Paperclip scientists and CIA mind-control experiments, to contemporary pharmacology, the impetus is the same. The methods have changed-needles to pills, black sites to pharmacies-but the concept is the same: the human body and brain as a test tube for experimentation, control, and profit.

VII. Microdosing and the Voluntary Laboratory

The newest frontier in neurochemical experimentation is voluntary, seductive, and sinister. Microdosing-ingesting sub-perceptual amounts of psychedelics such as LSD or psilocybin-is being touted as self-optimization, creativity boosting, or mood management. But it's an outgrowth of the same experimental ethos that underpinned MKUltra: manipulating consciousness, cognition, and behavior in controlled, quantifiable ways.

Unlike Cold War test subjects who were coerced, today's volunteers believe they are in command of their own decisions. They administer doses to themselves, monitor the effects closely, and supply data to Web forums. Behind the facade of consent and voluntarism lies the concealed truth: millions of minds are being dosed with psychoactives in a global, scattered experiment, driven by curiosity, culture, and commerce.

Pharma and biotech firms are taking note of these trends with interest. The normalization of microdosing and the medicalization of psychedelics (e.g., esketamine, MDMA therapy) provide an officially legitimized, socially accepted platform upon which to study and normalize psychoactive effects. That it is voluntary in no way diminishes its experimental value; it merely shifts apparatus from hidden to willing participation.

This affliction demonstrates a telling shift: the human subject is no longer confined to a prison cell or hospital bed. Humans, by their own volition, subject themselves to chemical influence over thought and feeling, unknowingly becoming a test subject in a grand social experiment. Microdosing under the guise of treatment or self-optimization continues the same controls, surveillance, and behavioral manipulation experimented with in the past under CIA secrecy.

The irony is sinister: what once was coerced, clandestine, and illegal is now voluntary, public, and fashionable. But the machinery-psychoactive chemicals, influence over behavior, and systematic alteration of consciousness-is identical. Society is laboratory and guinea pig, a mass of self-policing subjects of the current MKUltra experiment, organized under the guise of health and productivity.

VIII. Conclusion-The Continuum of Experimentation

These relationships between MKUltra, the Nazi chemical experiments, Operation Paperclip, and modern-day pharmaceuticals are not isolated or random. They are along a continuum: a scientific, corporate, and historical practice whereby human minds and bodies have been used as means for experimentation.

From concentration camp and asylum patient captives to Cold War prisoners and soldiers in laboratory settings, to twenty-first-century volunteers, the technique has evolved but not the principle. Control, monitoring, and manipulation of cognition and behavior are the goals-initially in secrecy, now in legality, consent, and cultural routinization.

Modern-day Big Pharma-in the guise of stimulants, SSRIs, opioids, and psychedelics-is continuing what was started all those decades ago, if on a worldwide, socially accepted scale. Enormous groups-children with ADHD to adults experimenting with microdosing-take part in large-scale chemical and psychological medication, unaware of the structural and historical forces informing their experience.

It is not a story of conspiracy; it is a story of systemic continuity. By exposing the pedigree-from Nazi experimentation, through CIA mind control experiments, to contemporary pharmaceutical practice-the mechanisms of social and psychological control are exposed. The moral implications are staggering, yet the evidence is irrefutable: the experiment continues, legalized, commercialized, and normalized.

Society, blind to its lack of knowledge, religion, or means of improvement, has turned on itself. MKUltra today is not in the shadows anymore but comes in the light of day, in schools, clinics, and households worldwide. This legacy accounts for not just the lines of descent of control through chemical modulation but how human behavior, intellect, and emotion are still being insidiously modeled.

Unveiling this continuum is the dawn of consciousness. Awareness of the past and the present, in all its totality of context, reveal the ongoing experiment in which mankind itself is the guinea pig.

This article does not constitute medical advice. Ask a skilled, licensed physician before making any lifestyle or medical changes.

APA Style Sources for "Big Pharma: The New MKUltra Experiment"

Section I Sources

Turner, T. (2025). Blue Zones and Longevity: Lessons from the World's Healthiest Centenarians. The People's Voice. https://www.thepeoplesvoice.org/TPV3/Voices.php/2025/05/01/blue-zones-and-longevity-n 

Hofmann, A. (1980). LSD: My Problem Child. McGraw-Hill.

Sagan, C. (1973). Cosmos. Random House.

Section II Sources

Marks, J. (1979). The Search for the “Manchurian Candidate”: The CIA and Mind Control. Times Books.

CIA. (1977). The MKUltra Program: Declassified Documents. U.S. Government Printing Office.

United States Congress. (1977). Senate Select Committee on Intelligence Report on MKUltra and Related Programs. Washington, D.C.: U.S. Senate.

Cameron, D. E. (1963). Psychic driving experiments. McGill University Archives.

Section III Sources

Kirsch, I. (2008). The Emperor's New Drugs: Exploding the Antidepressant Myth. Basic Books.

Angell, M. (2004). The Truth About the Drug Companies: How They Deceive Us and What to Do About It. Random House.

Whitaker, R. (2010). Anatomy of an Epidemic: Magic Bullets, Psychiatric Drugs, and the Astonishing Rise of Mental Illness in America. Crown Publishing.

Section IV Sources

Heller, M. (2016). "ADHD and the American stimulant culture." Journal of Attention Disorders, 20(3), 195–204. https://doi.org/10.1177/1087054712462473

Jensen, P. S., & Kenny, D. T. (2004). The role of psychostimulants in ADHD treatment: Cultural and clinical perspectives. Harvard Review of Psychiatry, 12(6), 316–329.

Faraone, S. V., & Biederman, J. (2002). "What is the prevalence of ADHD? Issues in epidemiology and diagnostic criteria." Journal of Child Psychology and Psychiatry, 43(6), 695–704.

Section V Sources

Van Zee, A. (2009). "The Promotion and Marketing of OxyContin: Commercial Triumph, Public Health Tragedy." American Journal of Public Health, 99(2), 155–157. https://doi.org/10.2105/AJPH.2007.131714

Kolodny, A., et al. (2015). "The prescription opioid and heroin crisis: A public health approach to an epidemic of addiction." Annual Review of Public Health, 36, 559–574.

Courtwright, D. T. (2001). Forces of Habit: Drugs and the Making of the Modern World. Harvard University Press.

Section VI Sources

Carhart-Harris, R., & Goodwin, G. M. (2017). "The therapeutic potential of psychedelic drugs: Past, present, and future." Neuropsychopharmacology, 42(11), 2105–2113.

Johnson, M. W., et al. (2014). "Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer." Journal of Psychopharmacology, 28(11), 983–992.

Nichols, D. E. (2016). "Psychedelics." Pharmacological Reviews, 68(2), 264–355.

Section VII Sources

Smith, J., & Young, K. (2018). "Microdosing psychedelics: The modern voluntary experiment." Journal of Psychoactive Drugs, 50(5), 411–420.

Kuypers, K. P. C., et al. (2019). "Microdosing psychedelics: Personality, mood, cognition, and creativity." Journal of Psychopharmacology, 33(9), 1151–1166.

Fadiman, J. (2011). The Psychedelic Explorer’s Guide: Safe, Therapeutic, and Sacred Journeys. Park Street Press.

Section VIII Sources

Marks, J. (1979). The Search for the “Manchurian Candidate”: The CIA and Mind Control. Times Books.

CIA. (1977). The MKUltra Program: Declassified Documents. U.S. Government Printing Office.

United States Congress. (1977). Senate Select Committee on Intelligence Report on MKUltra and Related Programs. Washington, D.C.: U.S. Senate.

###

Big Pharma: The New Paperclip MKUltra Experiment

Fred Gransville